1-4 of 4
Marcus O. Butler, MD
Close
Sort by
Journal Articles

4-1BB (CD137) or CD40 Signaling Fails To Improve the Expansion of Antigen Specific T Cells Demonstrated with Engagement of TCR, CD28 and CD83 Ligand.

Naoto Hirano, MD, PhD, Marcus O. Butler, MD, Lee M. Nadler, MD
Journal: Blood
Blood (2004) 104 (11): 2665.
https://doi.org/10.1182/blood.V104.11.2665.2665
Published: 2004
Journal Articles

Off the Shelf, GMP Grade Artificial APC Efficiently Generates Large Numbers of Antigen Specific CTLs Sufficient for the Treatment of Cancer and Infectious Disease.

Marcus O. Butler, MD, Naoto Hirano, MD/PhD, Jeng-Shin Lee, MD/PhD, E. Jeffrey Beecham, PhD, Mirra Chung, Robin Ripley, Andrew P. Murray, Richard C. Mulligan, PhD, Lee M. Nadler, MD
Journal: Blood
Blood (2004) 104 (11): 3172.
https://doi.org/10.1182/blood.V104.11.3172.3172
Published: 2004
Journal Articles

Highly Efficient Presentation of Endogenously Processed Class I Peptides by Artificial APC for the Generation of Effective Anti-Tumor Responses.

Naoto Hirano, MD. PhD, Marcus O. Butler, MD, Zhinan Xia, PhD, Lee M. Nadler, MD
Journal: Blood
Blood (2004) 104 (11): 1355.
https://doi.org/10.1182/blood.V104.11.1355.1355
Published: 2004
Journal Articles

γ-Globin, a Tumor-Associated Antigen for Juvenile Myelomonocytic Leukemia (JMML): A Cell-Based Approach To Identify Tumor Antigenic Epitopes That Are Naturally Processed and Presented.

Naoto Hirano, MD, PhD, Marcus O. Butler, MD, Zhinan Xia, PhD, Seiji Kojima, MD3, Lee M. Nadler, MD
Journal: Blood
Blood (2004) 104 (11): 3418.
https://doi.org/10.1182/blood.V104.11.3418.3418
Published: 2004